APO Research, Inc.

APO RESEARCH · REPORT

Joint Pain Injections

Selected research

Industry Growth & Trends

Global Joint Pain Injections Industry Growth and Trends Forecast to 2032

Market perspective

The global Joint Pain Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Joint Pain Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Joint Pain Injections include Chugai Pharmaceutical, Sanofi, Pfizer, Ferring, Zimmer Biomet Holdings, SEIKAGAKU CORPORATION, Flexion Therapeutics, Bioventus and Anika Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Joint Pain Injections market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Joint Pain Injections market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Joint Pain Injections market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Joint Pain Injections.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Joint Pain Injections market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Joint Pain Injections Market by Company

Chugai Pharmaceutical

Sanofi

Pfizer

Ferring

Zimmer Biomet Holdings

SEIKAGAKU CORPORATION

Flexion Therapeutics

Bioventus

Anika Therapeutics

Allergan

Joint Pain Injections Segment by Type

Corticosteroid Injections

Hyaluronic Acid Injections

Others

Joint Pain Injections Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Joint Pain Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Joint Pain Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Joint Pain Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Joint Pain Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Joint Pain Injections manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Joint Pain Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Corticosteroid Injections Table 2. Major Company of Hyaluronic Acid Injections Table 3. Major Company of Others Table 4. Global Joint Pain Injections Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 6. Global Joint Pain Injections Sales Market Share in Volume by Type (2021-2026) Table 7. Global Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 8. Global Joint Pain Injections Sales Market Share in Value by Type (2021-2026) Table 9. Global Joint Pain Injections Price by Type (2021-2026) & (US$/unit) Table 10. Global Joint Pain Injections Sales by Type (2027-2032) & (k units) Table 11. Global Joint Pain Injections Sales Market Share in Volume by Type (2027-2032) Table 12. Global Joint Pain Injections Sales by Type (2027-2032) & (US$ Million) Table 13. Global Joint Pain Injections Sales Market Share in Value by Type (2027-2032) Table 14. Global Joint Pain Injections Price by Type (2027-2032) & (US$/unit) Table 15. North America Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 16. North America Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 18. Europe Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 22. Latin America Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Joint Pain Injections Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Joint Pain Injections Sales by Type (2021-2026) & (US$ Million) Table 25. Joint Pain Injections Industry Trends Table 26. Joint Pain Injections Industry Drivers Table 27. Joint Pain Injections Industry Opportunities and Challenges Table 28. Joint Pain Injections Industry Restraints Table 29. Global Joint Pain Injections Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Joint Pain Injections Revenue Market Share by Company (2021-2026) Table 31. Global Joint Pain Injections Sales by Company (2021-2026) & (k units) Table 32. Global Joint Pain Injections Sales Share by Company (2021-2026) Table 33. Global Joint Pain Injections Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Joint Pain Injections Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Joint Pain Injections Major Company Production Sites and Headquarters Table 36. Global Joint Pain Injections Company, Product Type & Application Table 37. Global Joint Pain Injections Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Joint Pain Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Joint Pain Injections Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Joint Pain Injections Sales by Region (2021-2026) & (k units) Table 42. Global Joint Pain Injections Sales Market Share in Volume by Region (2021-2026) Table 43. Global Joint Pain Injections Sales by Region (2021-2026) & (US$ Million) Table 44. Global Joint Pain Injections Sales Market Share in Value by Region (2021-2026) Table 45. Global Joint Pain Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Joint Pain Injections Sales by Region (2027-2032) & (k units) Table 47. Global Joint Pain Injections Sales Market Share in Volume by Region (2027-2032) Table 48. Global Joint Pain Injections Sales by Region (2027-2032) & (US$ Million) Table 49. Global Joint Pain Injections Sales Market Share in Value by Region (2027-2032) Table 50. Global Joint Pain Injections Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Joint Pain Injections Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 53. Global Joint Pain Injections Sales Market Share in Volume by Application (2021-2026) Table 54. Global Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 55. Global Joint Pain Injections Sales Market Share in Value by Application (2021-2026) Table 56. Global Joint Pain Injections Price by Application (2021-2026) & (US$/unit) Table 57. Global Joint Pain Injections Sales by Application (2027-2032) & (k units) Table 58. Global Joint Pain Injections Sales Market Share in Volume by Application (2027-2032) Table 59. Global Joint Pain Injections Sales by Application (2027-2032) & (US$ Million) Table 60. Global Joint Pain Injections Sales Market Share in Value by Application (2027-2032) Table 61. Global Joint Pain Injections Price by Application (2027-2032) & (US$/unit) Table 62. North America Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 63. North America Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 65. Europe Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 69. Latin America Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Joint Pain Injections Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Joint Pain Injections Sales by Application (2021-2026) & (US$ Million) Table 72. Chugai Pharmaceutical Company Information Table 73. Chugai Pharmaceutical Business Overview Table 74. Chugai Pharmaceutical Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Chugai Pharmaceutical Joint Pain Injections Product Portfolio Table 76. Chugai Pharmaceutical Recent Development Table 77. Sanofi Company Information Table 78. Sanofi Business Overview Table 79. Sanofi Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Sanofi Joint Pain Injections Product Portfolio Table 81. Sanofi Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Pfizer Joint Pain Injections Product Portfolio Table 86. Pfizer Recent Development Table 87. Ferring Company Information Table 88. Ferring Business Overview Table 89. Ferring Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Ferring Joint Pain Injections Product Portfolio Table 91. Ferring Recent Development Table 92. Zimmer Biomet Holdings Company Information Table 93. Zimmer Biomet Holdings Business Overview Table 94. Zimmer Biomet Holdings Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Zimmer Biomet Holdings Joint Pain Injections Product Portfolio Table 96. Zimmer Biomet Holdings Recent Development Table 97. SEIKAGAKU CORPORATION Company Information Table 98. SEIKAGAKU CORPORATION Business Overview Table 99. SEIKAGAKU CORPORATION Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio Table 101. SEIKAGAKU CORPORATION Recent Development Table 102. Flexion Therapeutics Company Information Table 103. Flexion Therapeutics Business Overview Table 104. Flexion Therapeutics Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Flexion Therapeutics Joint Pain Injections Product Portfolio Table 106. Flexion Therapeutics Recent Development Table 107. Bioventus Company Information Table 108. Bioventus Business Overview Table 109. Bioventus Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Bioventus Joint Pain Injections Product Portfolio Table 111. Bioventus Recent Development Table 112. Anika Therapeutics Company Information Table 113. Anika Therapeutics Business Overview Table 114. Anika Therapeutics Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Anika Therapeutics Joint Pain Injections Product Portfolio Table 116. Anika Therapeutics Recent Development Table 117. Allergan Company Information Table 118. Allergan Business Overview Table 119. Allergan Joint Pain Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Allergan Joint Pain Injections Product Portfolio Table 121. Allergan Recent Development Table 122. North America Joint Pain Injections Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. North America Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 124. North America Joint Pain Injections Sales Market Share by Country (2021-2026) Table 125. North America Joint Pain Injections Sales Forecast by Country (2027-2032) & (k units) Table 126. North America Joint Pain Injections Sales Market Share Forecast by Country (2027-2032) Table 127. North America Joint Pain Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Joint Pain Injections Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Joint Pain Injections Market Share by Country (2021-2026) Table 130. North America Joint Pain Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Joint Pain Injections Market Share Forecast by Country (2027-2032) Table 132. Europe Joint Pain Injections Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Europe Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 134. Europe Joint Pain Injections Sales Market Share by Country (2021-2026) Table 135. Europe Joint Pain Injections Sales Forecast by Country (2027-2032) & (k units) Table 136. Europe Joint Pain Injections Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Joint Pain Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Joint Pain Injections Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Joint Pain Injections Market Share by Country (2021-2026) Table 140. Europe Joint Pain Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Joint Pain Injections Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Joint Pain Injections Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 144. Asia-Pacific Joint Pain Injections Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Joint Pain Injections Sales Forecast by Country (2027-2032) & (k units) Table 146. Asia-Pacific Joint Pain Injections Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Joint Pain Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Joint Pain Injections Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Joint Pain Injections Market Share by Country (2021-2026) Table 150. Asia-Pacific Joint Pain Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Joint Pain Injections Market Share Forecast by Country (2027-2032) Table 152. Latin America Joint Pain Injections Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Latin America Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 154. Latin America Joint Pain Injections Sales Market Share by Country (2021-2026) Table 155. Latin America Joint Pain Injections Sales Forecast by Country (2027-2032) & (k units) Table 156. Latin America Joint Pain Injections Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Joint Pain Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Joint Pain Injections Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Joint Pain Injections Market Share by Country (2021-2026) Table 160. Latin America Joint Pain Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Joint Pain Injections Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Joint Pain Injections Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Joint Pain Injections Sales by Country (2021-2026) & (k units) Table 164. Middle East and Africa Joint Pain Injections Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Joint Pain Injections Sales Forecast by Country (2027-2032) & (k units) Table 166. Middle East and Africa Joint Pain Injections Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Joint Pain Injections Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Joint Pain Injections Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Joint Pain Injections Market Share by Country (2021-2026) Table 170. Middle East and Africa Joint Pain Injections Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Joint Pain Injections Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Joint Pain Injections Distributors List Table 175. Joint Pain Injections Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Joint Pain Injections Image Figure 2. Global Joint Pain Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Joint Pain Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global Joint Pain Injections Sales (2021-2032) & (k units) Figure 5. Corticosteroid Injections Image Figure 6. Global Corticosteroid Injections Sales YoY Growth (2021-2032) & (k units) Figure 7. Hyaluronic Acid Injections Image Figure 8. Global Hyaluronic Acid Injections Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Joint Pain Injections Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Joint Pain Injections Market Share by Type 2025 VS 2032 Figure 13. North America Joint Pain Injections Sales Market Share in Volume by Type in 2025 Figure 14. North America Joint Pain Injections Sales Market Share in Value by Type in 2025 Figure 15. Europe Joint Pain Injections Sales Market Share in Volume by Type in 2025 Figure 16. Europe Joint Pain Injections Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Joint Pain Injections Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Joint Pain Injections Sales Market Share in Value by Type in 2025 Figure 19. Latin America Joint Pain Injections Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Joint Pain Injections Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Joint Pain Injections Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Joint Pain Injections Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Joint Pain Injections Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Joint Pain Injections Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Joint Pain Injections Market Share by Application 2025 VS 2032 Figure 33. North America Joint Pain Injections Sales Market Share in Volume by Application in 2025 Figure 34. North America Joint Pain Injections Sales Market Share in Value by Application in 2025 Figure 35. Europe Joint Pain Injections Sales Market Share in Volume by Application in 2025 Figure 36. Europe Joint Pain Injections Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Joint Pain Injections Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Joint Pain Injections Sales Market Share in Value by Application in 2025 Figure 39. Latin America Joint Pain Injections Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Joint Pain Injections Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Joint Pain Injections Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Joint Pain Injections Sales Market Share in Value by Application in 2025 Figure 43. North America Joint Pain Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Joint Pain Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Joint Pain Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Joint Pain Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Joint Pain Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Joint Pain Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Joint Pain Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Joint Pain Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Joint Pain Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Joint Pain Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Joint Pain Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Joint Pain Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Joint Pain Injections Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Joint Pain Injections Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Joint Pain Injections Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Joint Pain Injections Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Joint Pain Injections Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Joint Pain Injections Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Chugai Pharmaceutical
  • Sanofi
  • Pfizer
  • Ferring
  • Zimmer Biomet Holdings
  • SEIKAGAKU CORPORATION
  • Flexion Therapeutics
  • Bioventus
  • Anika Therapeutics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Joint Pain Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Joint Pain Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Joint Pain Injections Market by Type
  6. 1.3.1 Corticosteroid Injections
  7. 1.3.2 Hyaluronic Acid Injections
  8. 1.3.3 Others
  9. 1.4 Global Joint Pain Injections Market Size by Type
  10. 1.4.1 Global Joint Pain Injections Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Joint Pain Injections Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Joint Pain Injections Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Joint Pain Injections Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Joint Pain Injections Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Joint Pain Injections Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Joint Pain Injections Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Joint Pain Injections Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Joint Pain Injections Industry Trends
  2. 2.2 Joint Pain Injections Industry Drivers
  3. 2.3 Joint Pain Injections Industry Opportunities and Challenges
  4. 2.4 Joint Pain Injections Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Joint Pain Injections Revenue (2021-2026)
  2. 3.2 Global Top Players by Joint Pain Injections Sales (2021-2026)
  3. 3.3 Global Top Players by Joint Pain Injections Price (2021-2026)
  4. 3.4 Global Joint Pain Injections Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Joint Pain Injections Major Company Production Sites & Headquarters
  6. 3.6 Global Joint Pain Injections Company, Product Type & Application
  7. 3.7 Global Joint Pain Injections Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Joint Pain Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Joint Pain Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Joint Pain Injections Tier 1, Tier 2, and Tier 3
4 Joint Pain Injections Regional Status and Outlook
  1. 4.1 Global Joint Pain Injections Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Joint Pain Injections Historic Market Size by Region
  3. 4.2.1 Global Joint Pain Injections Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Joint Pain Injections Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Joint Pain Injections Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Joint Pain Injections Forecasted Market Size by Region
  7. 4.3.1 Global Joint Pain Injections Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Joint Pain Injections Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Joint Pain Injections Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Joint Pain Injections by Application
  1. 5.1 Joint Pain Injections Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Joint Pain Injections Market Size by Application
  6. 5.2.1 Global Joint Pain Injections Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Joint Pain Injections Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Joint Pain Injections Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Joint Pain Injections Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Joint Pain Injections Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Joint Pain Injections Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Joint Pain Injections Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Joint Pain Injections Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chugai Pharmaceutical
  2. 6.1.1 Chugai Pharmaceutical Company Information
  3. 6.1.2 Chugai Pharmaceutical Business Overview
  4. 6.1.3 Chugai Pharmaceutical Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chugai Pharmaceutical Joint Pain Injections Product Portfolio
  6. 6.1.5 Chugai Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Joint Pain Injections Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Joint Pain Injections Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Ferring
  20. 6.4.1 Ferring Company Information
  21. 6.4.2 Ferring Business Overview
  22. 6.4.3 Ferring Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ferring Joint Pain Injections Product Portfolio
  24. 6.4.5 Ferring Recent Developments
  25. 6.5 Zimmer Biomet Holdings
  26. 6.5.1 Zimmer Biomet Holdings Company Information
  27. 6.5.2 Zimmer Biomet Holdings Business Overview
  28. 6.5.3 Zimmer Biomet Holdings Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zimmer Biomet Holdings Joint Pain Injections Product Portfolio
  30. 6.5.5 Zimmer Biomet Holdings Recent Developments
  31. 6.6 SEIKAGAKU CORPORATION
  32. 6.6.1 SEIKAGAKU CORPORATION Company Information
  33. 6.6.2 SEIKAGAKU CORPORATION Business Overview
  34. 6.6.3 SEIKAGAKU CORPORATION Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SEIKAGAKU CORPORATION Joint Pain Injections Product Portfolio
  36. 6.6.5 SEIKAGAKU CORPORATION Recent Developments
  37. 6.7 Flexion Therapeutics
  38. 6.7.1 Flexion Therapeutics Company Information
  39. 6.7.2 Flexion Therapeutics Business Overview
  40. 6.7.3 Flexion Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Flexion Therapeutics Joint Pain Injections Product Portfolio
  42. 6.7.5 Flexion Therapeutics Recent Developments
  43. 6.8 Bioventus
  44. 6.8.1 Bioventus Company Information
  45. 6.8.2 Bioventus Business Overview
  46. 6.8.3 Bioventus Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bioventus Joint Pain Injections Product Portfolio
  48. 6.8.5 Bioventus Recent Developments
  49. 6.9 Anika Therapeutics
  50. 6.9.1 Anika Therapeutics Company Information
  51. 6.9.2 Anika Therapeutics Business Overview
  52. 6.9.3 Anika Therapeutics Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Anika Therapeutics Joint Pain Injections Product Portfolio
  54. 6.9.5 Anika Therapeutics Recent Developments
  55. 6.10 Allergan
  56. 6.10.1 Allergan Company Information
  57. 6.10.2 Allergan Business Overview
  58. 6.10.3 Allergan Joint Pain Injections Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Allergan Joint Pain Injections Product Portfolio
  60. 6.10.5 Allergan Recent Developments
7 North America by Country
  1. 7.1 North America Joint Pain Injections Sales by Country
  2. 7.1.1 North America Joint Pain Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Joint Pain Injections Sales by Country (2021-2026)
  4. 7.1.3 North America Joint Pain Injections Sales Forecast by Country (2027-2032)
  5. 7.2 North America Joint Pain Injections Market Size by Country
  6. 7.2.1 North America Joint Pain Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Joint Pain Injections Market Size by Country (2021-2026)
  8. 7.2.3 North America Joint Pain Injections Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Joint Pain Injections Sales by Country
  2. 8.1.1 Europe Joint Pain Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Joint Pain Injections Sales by Country (2021-2026)
  4. 8.1.3 Europe Joint Pain Injections Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Joint Pain Injections Market Size by Country
  6. 8.2.1 Europe Joint Pain Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Joint Pain Injections Market Size by Country (2021-2026)
  8. 8.2.3 Europe Joint Pain Injections Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Joint Pain Injections Sales by Country
  2. 9.1.1 Asia-Pacific Joint Pain Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Joint Pain Injections Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Joint Pain Injections Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Joint Pain Injections Market Size by Country
  6. 9.2.1 Asia-Pacific Joint Pain Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Joint Pain Injections Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Joint Pain Injections Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Joint Pain Injections Sales by Country
  2. 10.1.1 South America Joint Pain Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Joint Pain Injections Sales by Country (2021-2026)
  4. 10.1.3 South America Joint Pain Injections Sales Forecast by Country (2027-2032)
  5. 10.2 South America Joint Pain Injections Market Size by Country
  6. 10.2.1 South America Joint Pain Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Joint Pain Injections Market Size by Country (2021-2026)
  8. 10.2.3 South America Joint Pain Injections Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Joint Pain Injections Sales by Country
  2. 11.1.1 Middle East and Africa Joint Pain Injections Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Joint Pain Injections Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Joint Pain Injections Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Joint Pain Injections Market Size by Country
  6. 11.2.1 Middle East and Africa Joint Pain Injections Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Joint Pain Injections Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Joint Pain Injections Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Joint Pain Injections Value Chain Analysis
  2. 12.1.1 Joint Pain Injections Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Joint Pain Injections Production Mode & Process
  7. 12.2 Joint Pain Injections Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Joint Pain Injections Distributors
  10. 12.2.3 Joint Pain Injections Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.